Clinical Profile Of Multiple Myeloma
Not Applicable
- Conditions
- Health Condition 1: C900- Multiple myeloma
- Registration Number
- CTRI/2021/08/035576
- Lead Sponsor
- Kasturba Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Newly diagnosed and previously diagnosed untreated patients of MM coming to Kasturba hospital, Manipal will be included in the study.
Diagnosis will be confirmed according to revised IMWG criteria
Exclusion Criteria
Patients of multiple myeloma who are already on treatment
Patients with other co-existing malignancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluate the common clinical and laboratory features, stages, and outcome after primary treatment of patients with Multiple Myeloma and correlate LDH levels as a response markerTimepoint: Evaluate the common clinical and laboratory features, stage including serum ldh level at the time of diagnosis (baseline), and outcome after primary treatment of patients with Multiple Myeloma which will be after 4 months and correlate baseline LDH levels as a response marker
- Secondary Outcome Measures
Name Time Method correlate LDH levels as a response markerTimepoint: correlate pretreatment LDH levels as a response marker after primary treatment with 4 cycles of chemotherapy after 4 months